Guido Kroemer
19Patents
4h-index
33Co-inventors
60Inventor score
Filing activity: May 20, 1996 → Feb 16, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6319931A | Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy | Human Necessities | 64 | Expired |
| US5776947A | Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock | Chemistry; Metallurgy | 40 | Expired |
| US8865653B2 | Method of treatment for immunogenic treatment resistant cancer | Chemistry; Metallurgy | 7 | Active |
| US8557517B2 | Toll like receptor 4 dysfunction and the biological applications thereof | Chemistry; Metallurgy | 4 | Active |
| US8263344B2 | Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment | Physics | 3 | Active |
| US6773911B1 | Apoptosis-inducing factor | Human Necessities | 3 | Expired |
| US7056735B2 | Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator) | Physics | 2 | Expired |
| US9132123B2 | Combined therapy for cystic fibrosis | Human Necessities | 2 | Active |
| US7642051B2 | Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT) | Physics | 2 | Expired |
| US8129340B2 | Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof | Physics | 2 | Active |
| US8828944B2 | Compounds and uses thereof to induce an immunogenic cancer cell death in a subject | Chemistry; Metallurgy | 1 | Active |
| US7371834B2 | Apoptosis-inducing factor | Human Necessities | 1 | Expired |
| US9726661B2 | Simultaneous detection of cannibalism and senescence as prognostic marker for cancer | Physics | 0 | Active |
| US11905330B1 | Methods for weight reduction | Chemistry; Metallurgy | 0 | Active |
| US12343376B2 | Methods for inhibiting diazepam binding protein | Chemistry; Metallurgy | 0 | Active |
| US9938528B2 | Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections | Chemistry; Metallurgy | 0 | Active |
| US10969380B2 | Simultaneous detection of cannibalism and senescence as prognostic marker for cancer | Physics | 0 | Active |
| US11040052B2 | Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof | Human Necessities | 0 | Active |
| US9730922B2 | Combined therapy for cystic fibrosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.